XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.

XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.
R
R

RECSilicon

Nachrichten

Reuters - vor 1 Woche

Italy - Factors to watch on July 9

Italy - Factors to watch on July 9 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury to sell up to 8.5 billion euros in bonds at July 11 auction .
A
A
B
E
I
L
P
R
A
I
U
Reuters - vor 2 Wochen

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Liberty Global, Crest Nicholson, NCR Voyix and Baxter International July 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2 000 GMT on Friday: * * Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's BAX.N kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters.
B
B
B
C
G
H
R
S
T
U
B
T
Reuters - vor 2 Wochen

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Thyssenkrupp, Dompe Farmaceutici, Crest Nicholson Updates: BBVA July 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Thyssenkrupp TKGA.DE , Salzgitter SZGG.DE and France's Vallourec VLLP.PA are reviewing a sale of their steel joint venture HKM after they were approached by a potential buyer, Germany's largest steelmaker said.
B
B
C
G
H
R
S
T
U
B
T
Reuters - vor 2 Wochen

Italy's Dompe not interested in possible deal with rival drugmaker Recordati

Italy's Dompe not interested in possible deal with rival drugmaker Recordati MILAN, July 5 (Reuters) - Italy's Dompe Farmaceutici is not interested in rival drugmaker Recordati RECI.MI , the biopharmaceutical group's chief executive and chairman said on Friday. "We had looked at it... it is a large company ...we are not on the file," Sergio Dompe told Reuter.
R
Reuters - vor 4 Wochen

Recordati shares rise as investors reportedly circle CVC stake

Recordati shares rise as investors reportedly circle CVC stake MILAN, June 18 (Reuters) - Shares in Italian drugmaker Recordati RECI.MI rose almost 3% on Tuesday, boosted by a report that investment funds KKR KKR.N and TPG TPG.O had expressed preliminary interest in buying a stake in the company. Speculation about the future of Recordati has increased after majority shareholder CVC Capital Partners CVC.AS hired investment banks JP Morgan and Goldman Sachs to explore options for the pharmaceutica
R
Reuters - vor 4 Wochen

Recordati rises after media report on KKR, TPG interest

BUZZ-Recordati rises after media report on KKR, TPG interest ** Shares in Recordati RECI.MI rise as much as 3% after Bloomberg News reported that KKR KKR.N and TPG TPG.O expressed interest in buying a stake in the Italian drugmaker ** The two investment funds, pharma company Angelini Pharma and an Abu Dhabi sovereign fund are among suitors for part or all of the 51.8% stake owned by CVC Capital Partners, Bloomberg News said on Monday, citing people familiar with the matter ** CVC declined to com
R
Reuters - vor 4 Wochen

Italy - Factors to watch on June 18

Italy - Factors to watch on June 18 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . COMPANIES UNICREDIT CRDI.MI The bank said on Monday it was "well above " MREL requirements set by the Single Resolution Board (SRB) and the Bank of Italy, with MREL eligible liabilities equal to 32.8% of risk-weighe
A
E
I
I
L
L
M
R
U
A
B
B
F
I
U
Reuters - vor 4 Wochen

KKR, TPG express interest in Italian drugmaker Recordati - Bloomberg News

MEDIA-KKR, TPG express interest in Italian drugmaker Recordati - Bloomberg News -- Source link: https://tinyurl.com/28c759fu -- Note: Reuters has not verified this story and does not vouch for its accuracy
R
Reuters - vor 1 Monat

Eiffage, Quilter, Ricardo

EUROPE RESEARCH ROUNDUP-Eiffage, Quilter, Ricardo June 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Eiffage, Quilter and Ricardo, on Monday. HIGHLIGHTS * Acciona Energia ANE.MC : Morgan Stanley raises to equalweight from underweight * Eiffage FOUG.PA : Goldman Sachs raises to buy from neutral * Quilter Plc QLT.L : JP Morgan raises to overweight from neutral * Ricardo Plc RCDO.L : Berenberg raises to buy from hold * St.
B
C
C
E
H
H
I
I
J
P
P
R
S
V
D
L
N
Reuters - vor 2 Monaten

Carlsberg, Danske Bank, Teleperformance

EUROPE RESEARCH ROUNDUP- Carlsberg, Danske Bank, Teleperformance May 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Carlsberg, Danske Bank and Teleperformance, on Friday. HIGHLIGHTS * Carlsberg A/S CARLB.CO : HSBC raises target price to DKK 1040 from DKK 1030 * Danske Bank DANSKE.CO : HSBC cuts target price to DKK 231 from DKK 238 * Hermes HRMS.PA : Jefferies initiates coverage with buy rating; price target EUR 2,650 * Rathbone
3
A
A
A
B
B
B
B
B
C
C
C
C
D
F
G
G
H
I
K
L
M
P
P
R
S
S
S
T
V
W
Z
A
D
S
S
Reuters - vor 2 Monaten

Italy's Recordati CEO: shareholder CVC committed to company long-term growth

BRIEF-Italy's Recordati CEO: shareholder CVC committed to company long-term growth May 9 (Reuters) - Recordati CEO Rob Koremans tells analysts: CVC, AS A SHAREHOLDER, IS VERY COMMITTED TO THE COMPANY'S LONG-TERM GROWTH M&A IS AN IMPORTANT PART OF OUR STRATEGY, VERY HAPPY IF THE NEXT DEAL COULD BE IN RARE DESEASE BUSINESS Further company coverage: R
R
Reuters - vor 2 Monaten

Italy's Recordati confirms guidance after robust Q1 performance

Italy's Recordati confirms guidance after robust Q1 performance May 9 (Reuters) - Italian drug maker Recordati RECI.MI posted a 10.5% rise in its first-quarter core profit on Thursday and confirmed its guidance for 2024 and 2025. The company said it had seen a "robust performance... across all key geographies and products". Interest, taxes, depreciation and amortisation (EBITDA) rose to 244.0 million euros ($262 million) with a margin of 40.2% for the January-March quarter, the Milan-based compa
R
Reuters - vor 2 Monaten

Recordati Q1 EBITDA Up To EUR 244.0 Mln

BRIEF-Recordati Q1 EBITDA Up To EUR 244.0 Mln May 9 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI : Q1 EBITDA EUR 244.0 MILLION VERSUS EUR 220.8 MILLION YEAR AGO CONFIRMS GUIDANCE FOR 2024 AND 2025 Q1 ADJUSTED NET PROFIT EUR 163.7 MILLION VERSUS EUR 155.0 MILLION YEAR AGO Further company coverage: RECI.MI Reporting by Gdansk Ne
R
Reuters - vor 2 Monaten

Italy - Factors to watch on May 9

Italy - Factors to watch on May 9 The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury sells 7.5 billion euros 12-month BOT bills. Subscriptions close at 0900 GMT.
A
B
E
I
I
L
L
P
R
S
S
T
U
A
B
B
B
B
D
F
P
T
I
U
Reuters - vor 2 Monaten

CVC picks banks to explore options for Italy's pharma group Recordati - sources

CVC picks banks to explore options for Italy's pharma group Recordati - sources MILAN, May 8 (Reuters) - CVC Capital Partners has hired JP Morgan and Goldman Sachs to explore options for Italian pharmaceutical group Recordati RECI.MI , two sources close to the matter said on Wednesday. The private equity firm, which owns a majority stake in Recordati, is considering all options, including a sale, a merger with another healthcare company or the creation of a so-called continuation fund, the sourc
G
R
Reuters - vor 2 Monaten

Italy - Factors to watch on May 7

Italy - Factors to watch on May 7 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Italy's rightwing coalition on Monday passed rules curbing the installation of solar panels on agricultural land , ministers said, in a move that triggered criticism as it could undermine Rome's decarbonisati
F
I
L
L
R
S
U
A
A
B
M
T
I
U
Reuters - vor 3 Monaten

Italy - Factors to watch on April 24

Italy - Factors to watch on April 24 The following factors could affect Italian markets on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Italy's Senate gave final approval on Tuesday to a contested government plan to allow groups who "support motherhood" into abortion clinics to try to deter women from terminating pregnancies.
A
A
E
E
F
M
R
U
A
A
D
I
J
S
T
I
U
Reuters - vor 3 Monaten

CVC explores options for Italy's Recordati, Bloomberg News reports

UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports Adds details and background from paragraph 2 onwards April 23 (Reuters) - CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA RECI.MI , Bloomberg News reported on Tuesday, citing people familiar with the matter.
R
Reuters - vor 3 Monaten

CVC explores options for Italy's Recordati, Bloomberg News reports

CVC explores options for Italy's Recordati, Bloomberg News reports April 23 (Reuters) - CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA RECI.MI , Bloomberg News reported on Tuesday, citing people familiar with the matter. Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Shilpi Majumdar
R
Reuters - vor 3 Monaten

Cvc Explores Options For €11 Billion Drugmaker Recordati - Bloomberg News

BRIEF-Cvc Explores Options For €11 Billion Drugmaker Recordati - Bloomberg News April 23 (Reuters) - CVC EXPLORES OPTIONS FOR €11 BILLION DRUGMAKER RECORDATI - BLOOMBERG NEWS Source text for Eikon: https://tinyurl.com/khdn87uv Further company coverage: RECI.MI
R

Konditionen

Beliebte Finanzwerte

Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.

Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.

Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.

Risikowarnung: Es bestehen Risiken für Ihr eingesetztes Kapital. Gehebelte Produkte sind nicht für alle Anleger geeignet. Bitte beachten Sie unseren Risikohinweis.